FPRX
Five Prime Therapeutics, Inc.
A biotechnology company that discovered and developed protein-based medicines and antibodies to treat cancer and inflammatory diseases. Founded in 2001 by physician-scientist Lewis "Rusty" Williams, it took its name from the "five prime" end of a DNA or RNA molecule, the starting point for genetic processes. Its lead drug, bemarituzumab, targets a protein linked to gastric cancer, and the company was acquired by Amgen in 2021.
CUSIP: 33830X104HealthcareUS1 holder
Recent Activity
2018Q3
1 sell
-183.1K shares
ARK InvestEXIT
-183.1K shares
2018Q2
1 buy
+114.2K shares(+165.9%)
ARK InvestADD
+114.2K shares(+165.9%)
2018Q1
1 buy
+25.6K shares(+59.3%)
ARK InvestADD
+25.6K shares(+59.3%)
Loading more activity...